your market intelligence analyst
Search Results
27 results
Your search is now limited to «Excipients» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
PR Newswire 12/02/2019 20:00
TOKYO, Dec. 2, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the presentation of new data in acute myeloid leukemia (AML) at the 61st American Society of Hematology (ASH) Annual Meeting, taking place Dec. 7-10...
PR Newswire 11/20/2019 03:00
BUFFALO GROVE, Ill., Nov. 20, 2019 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer and marketer of specialty and fine chemicals, today announced the availability of the first commercial volumes of TRIS AMINO™ tromethamine crystals from the...
PR Newswire 11/05/2019 08:05
Dr. Dadi Segal, Panaxia CEO: "Prof. Veit is key to our effort to successfully register our pharmaceutical cannabis for European markets" TEL-AVIV, Israel, Nov. 5, 2019 /PRNewswire/ -- Panaxia Pharmaceutical Industries, the largest manufacturer and distributor of pharmaceutical cannabis in...
PR Newswire 10/31/2019 16:35
STAINES-UPON-THAMES, United Kingdom, Oct. 31, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that UVADEX® (methoxsalen) has received regulatory approval in Australia by the Therapeutic Goods Administration (TGA) for extracorporeal...
PR Newswire 10/22/2019 06:00
EXTON, Pa., Oct. 22, 2019 /PRNewswire/ -- (Booths #F44 & #F51)—West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings at the 2019 PDA Universe of Pre-Filled Syringes and...
PR Newswire 10/12/2019 06:45
INDIANAPOLIS, Oct. 12, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz met co-primary endpoints as well as all major secondary endpoints in a Phase 3 study in pediatric patients with moderate to severe plaque psoriasis, demonstrating that 89 percent of...
PR Newswire 10/10/2019 16:15
DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in an exploratory Phase 2 clinical trial evaluating the ability of defibrotide to prevent neurotoxicity in patients with relapsed or refractory diffuse...

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities


Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications